Home Lilly And AstraZeneca Expand Immuno-Oncology Research Collaboration With New Combinations
 

Keywords :   


Lilly And AstraZeneca Expand Immuno-Oncology Research Collaboration With New Combinations

2015-10-26 04:26:54| drugdiscoveryonline News Articles

Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE:AZN) today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.

Tags: research expand collaboration combinations

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »